PGRN PSYCHIATRY SPECIAL INTEREST GROUP
The “Pharmacogenetics in Psychiatry Interest Group (PPIG)” has evolved as a sub-group with support from the Pharmacogenomic Global Research Network (PGRN) leadership. Established in March 2021, the PPIG meets every two months and aims to bring together scientists from all over the world, working in academia and industry, interested in the exciting and emerging field of Psychiatric Pharmacogenomics.
our virtual meetings, we will discuss and disseminate ongoing and
prospective research related to the implementation of PGx into the
psychiatric clinical practice, including cost reimbursement and
electronic health record opportunities. Given the diverse nature of our
group, researchers have the opportunity to drive different healthcare
systems and regimes, learn, adopt strategies that fit their
organizations and be better prepared to act as implementers. Moreover,
group members will actively engage in networking and assist early career
researchers in their career planning and facilitate contacts to senior
researchers in Psychiatric PGx. Educational and knowledge translation
activities are organized in conjunction with PGRN and linked to larger
conferences where in-person meetings are organized. The group is
committed to promoting and addressing equity, diversity, and inclusion
in research and clinical practice. As the group evolves, we will seek
publication and funding opportunities to achieve maximum output through
joint efforts. To serve our purpose, we welcome new members and
volunteers from across the globe to join our meetings, especially from
developing countries, and help in the organization and curation of our
PSYCHIATRY INTEREST GROUP SEMINAR
Role of polymorphic CYP2C19 and CYP2D6 enzymes in psychiatric phenotypes and psychiatric drug metabolism
Thursday, December 1, 2022, 12-2 pm EST
Presenter: Assoc. Prof. Marin Jukić, PharmD
Dr. Marin Jukić earned an MSc degree in pharmacy at the University of Belgrade, Serbia, completed his PhD in neuroscience at Ben Gurion University, Israel, and received postdoctoral training at Karolinska Institute, Sweden. Marin is currently employed as an associate professor at the University of Belgrade and a senior researcher at Karolinska Institute. Dr. Marin Jukić research is focused on brain development, monoaminergic neurotransmission, neuropsychopharmacology, and pharmacogenetics in psychiatry.
PGRN awards, seminars and meetings are open to Members Only.
Join now so you can take advantage of PGRN's seminars, research in progress sessions,
tool kits and awards.